Fig. 1
From: One year of ETI reduces lung bacterial colonisation in adults with cystic fibrosis
Evolution of clinical features. (A) evolution of lung function before and after ETI, ppFEV1%. (B) Evolution of respiratory symptoms, estimated by the frequency of weekly physiotherapy sessions and the number of PEx per patient per year. (C) Evolution of treatment load, focusing on pulmonary treatments: mucolytic agents, inhaled antibiotics, azithromycin. (D) Evolution of number of inpatients per year and length of stay hospitalisations stay.
